EXAMINE THIS REPORT ON SODIUM PENTOBARBITAL SDS

pentobarbital will decrease the extent or effect of buprenorphine, lengthy-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Sufferers who transfer to buprenorphine lengthy-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers ought to be monitored to make